Anzeige
Mehr »
Donnerstag, 07.08.2025 - Börsentäglich über 12.000 News
Große CEO-Enthüllung: Analysten sehen +56% Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41APT | ISIN: CA75103L3092 | Ticker-Symbol: 7JO0
Tradegate
07.08.25 | 10:21
0,314 Euro
+0,96 % +0,003
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RAKOVINA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
RAKOVINA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2970,31513:09

Aktuelle News zur RAKOVINA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.07.Rakovina Therapeutics Inc (2): Rakovina grants options to buy 540,000 shares6
30.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre257VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies...
► Artikel lesen
29.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Stock Option Grants3
25.07.Rakovina Therapeutics Inc (2): Rakovina implements warrant exercise incentive program4
RAKOVINA THERAPEUTICS Aktie jetzt für 0€ handeln
24.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Warrant Exercise Incentive Program1
23.07.Rakovina Therapeutics Inc (2): Rakovina's KT-5000AI generates ATR inhibitor candidates1
23.07.Rakovina Therapeutics Inc: Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening342VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V:?RKV) (FSE:?7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
15.07.Rakovina Therapeutics Inc (2): Rakovina Therapeutics receives DTC eligibility7
15.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access150VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
13.07.Diese Aktie zeigt die wissenschaftliche Schlagkraft hinter ihrer KI-gesteuerten Krebsforschung
11.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC's 2025 Emerging Biotech Company of the Year Award30
10.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development4
01.07.Rakovina Therapeutics Inc (2): Rakovina to seek TSX-V OK to amend warrants, debentures48
01.07.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants29
30.06.Rakovina Therapeutics Inc (2): Rakovina plans kt-3283 development partnerships for Q321
30.06.Rakovina Therapeutics Inc: Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025384VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation...
► Artikel lesen
26.06.Rakovina Therapeutics Inc (2): Rakovina shareholders elect five directors at AGM6
26.06.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Results from 2025 Annual General Meeting208VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) ("Rakovina" or the "Company"), a biopharmaceutical company advancing next-generation...
► Artikel lesen
24.06.XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025762The following instruments on XETRA do have their first trading 24.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.06.2025 Aktien 1 NL0015002J37 JBS N.V. 2 AU0000400616...
► Artikel lesen
23.06.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.06.2025737The following instruments on Boerse Frankfurt do have their last trading day on 23.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.06.2025ISIN NameCA39261L2049 GREEN...
► Artikel lesen
Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1